Ontology type: schema:ScholarlyArticle Open Access: True
1997-01
AUTHORSWei-Shou Hu, Julie R. Friend, Florence J. Wu, Timothy Sielaff, Madhusudan V. Peshwa, Arye Lazar, Scott L. Nyberg, Rory P. Remmel, Frank B. Cerra
ABSTRACTLiver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations. More... »
PAGES29-38
http://scigraph.springernature.com/pub.10.1023/a:1007906512616
DOIhttp://dx.doi.org/10.1023/a:1007906512616
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1002483814
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/22358518
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Technology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Hu",
"givenName": "Wei-Shou",
"id": "sg:person.01064261433.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064261433.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Friend",
"givenName": "Julie R.",
"id": "sg:person.0642163715.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642163715.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Wu",
"givenName": "Florence J.",
"id": "sg:person.01365570015.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365570015.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Sielaff",
"givenName": "Timothy",
"id": "sg:person.0667256104.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667256104.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Peshwa",
"givenName": "Madhusudan V.",
"id": "sg:person.01306202160.55",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306202160.55"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Lazar",
"givenName": "Arye",
"id": "sg:person.016461535432.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016461535432.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Nyberg",
"givenName": "Scott L.",
"id": "sg:person.01260246357.46",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260246357.46"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicinal Chemistry, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Department of Medicinal Chemistry, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Remmel",
"givenName": "Rory P.",
"id": "sg:person.01267470403.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267470403.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN",
"id": "http://www.grid.ac/institutes/grid.17635.36",
"name": [
"Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN"
],
"type": "Organization"
},
"familyName": "Cerra",
"givenName": "Frank B.",
"id": "sg:person.015711213420.76",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015711213420.76"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf02722946",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028865471",
"https://doi.org/10.1007/bf02722946"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01307531",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020837436",
"https://doi.org/10.1007/bf01307531"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf02634282",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020247813",
"https://doi.org/10.1007/bf02634282"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-96629-3_43",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007304278",
"https://doi.org/10.1007/978-3-642-96629-3_43"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf02626175",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032988930",
"https://doi.org/10.1007/bf02626175"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf02782889",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1082827506",
"https://doi.org/10.1007/bf02782889"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-96629-3_41",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000888130",
"https://doi.org/10.1007/978-3-642-96629-3_41"
],
"type": "CreativeWork"
}
],
"datePublished": "1997-01",
"datePublishedReg": "1997-01-01",
"description": "Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations.",
"genre": "article",
"id": "sg:pub.10.1023/a:1007906512616",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1086307",
"issn": [
"1381-5741",
"1573-0603"
],
"name": "Cytotechnology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1-3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "23"
}
],
"keywords": [
"hollow fiber bioreactor",
"liver-specific functions",
"higher liver-specific functions",
"anticipated clinical applications",
"mixture of spheroids",
"bioartificial liver",
"large-scale preparation",
"liver-specific metabolic activity",
"self-assembled spheroids",
"collagen entrapment",
"tank bioreactor",
"bioreactor system",
"canine liver failure model",
"hepatocyte spheroids",
"liver-specific activity",
"bioreactor",
"anhepatic rabbits",
"rate control",
"flow rate control",
"high yield",
"clinical applications",
"surface requirements",
"monolayers",
"xenogeneic hepatocytes",
"porcine hepatocytes",
"spheroid formation",
"protocol",
"spheroids",
"applications",
"conjugation",
"metabolic activity",
"liver failure model",
"preparation",
"oxygen measurements",
"entrapment",
"suspension",
"requirements",
"animal treatment",
"mixture",
"yield",
"possibility",
"sufficient number",
"viability",
"biosynthesis",
"biotransformation",
"development",
"system",
"proper degree",
"measurements",
"activity",
"formation",
"monolayer cultures",
"cells",
"high levels",
"end",
"hepatocytes",
"temporary support",
"order",
"control",
"first phase",
"phase",
"use",
"luminal side",
"function",
"side",
"investigation",
"support",
"culture",
"rat hepatocytes",
"test animals",
"number",
"perfusion protocol",
"collagen",
"scale",
"levels",
"degree",
"study",
"liver",
"further investigation",
"failure model",
"liver failure patients",
"rabbits",
"treatment",
"major cause",
"model",
"series",
"liver failure",
"tank",
"animals",
"failure",
"oxygenator",
"collagen gel contraction",
"gel contraction",
"dogs",
"warrants further investigation",
"contraction",
"rats",
"cause",
"survival",
"improved survival",
"failure patients",
"overdose",
"patients",
"mortality"
],
"name": "Development of a bioartificial liver employing xenogeneic hepatocytes",
"pagination": "29-38",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1002483814"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1023/a:1007906512616"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"22358518"
]
}
],
"sameAs": [
"https://doi.org/10.1023/a:1007906512616",
"https://app.dimensions.ai/details/publication/pub.1002483814"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:20",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_294.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1023/a:1007906512616"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'
This table displays all metadata directly associated to this object as RDF triples.
258 TRIPLES
22 PREDICATES
139 URIs
123 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1023/a:1007906512616 | schema:about | anzsrc-for:06 |
2 | ″ | ″ | anzsrc-for:10 |
3 | ″ | ″ | anzsrc-for:11 |
4 | ″ | schema:author | N610be4845a6a4a93b0052afc66f1f635 |
5 | ″ | schema:citation | sg:pub.10.1007/978-3-642-96629-3_41 |
6 | ″ | ″ | sg:pub.10.1007/978-3-642-96629-3_43 |
7 | ″ | ″ | sg:pub.10.1007/bf01307531 |
8 | ″ | ″ | sg:pub.10.1007/bf02626175 |
9 | ″ | ″ | sg:pub.10.1007/bf02634282 |
10 | ″ | ″ | sg:pub.10.1007/bf02722946 |
11 | ″ | ″ | sg:pub.10.1007/bf02782889 |
12 | ″ | schema:datePublished | 1997-01 |
13 | ″ | schema:datePublishedReg | 1997-01-01 |
14 | ″ | schema:description | Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations. |
15 | ″ | schema:genre | article |
16 | ″ | schema:inLanguage | en |
17 | ″ | schema:isAccessibleForFree | true |
18 | ″ | schema:isPartOf | N2edeefe42b87456b837a900d86f627be |
19 | ″ | ″ | Nd923715ab7334466b14237f9b254bbbb |
20 | ″ | ″ | sg:journal.1086307 |
21 | ″ | schema:keywords | activity |
22 | ″ | ″ | anhepatic rabbits |
23 | ″ | ″ | animal treatment |
24 | ″ | ″ | animals |
25 | ″ | ″ | anticipated clinical applications |
26 | ″ | ″ | applications |
27 | ″ | ″ | bioartificial liver |
28 | ″ | ″ | bioreactor |
29 | ″ | ″ | bioreactor system |
30 | ″ | ″ | biosynthesis |
31 | ″ | ″ | biotransformation |
32 | ″ | ″ | canine liver failure model |
33 | ″ | ″ | cause |
34 | ″ | ″ | cells |
35 | ″ | ″ | clinical applications |
36 | ″ | ″ | collagen |
37 | ″ | ″ | collagen entrapment |
38 | ″ | ″ | collagen gel contraction |
39 | ″ | ″ | conjugation |
40 | ″ | ″ | contraction |
41 | ″ | ″ | control |
42 | ″ | ″ | culture |
43 | ″ | ″ | degree |
44 | ″ | ″ | development |
45 | ″ | ″ | dogs |
46 | ″ | ″ | end |
47 | ″ | ″ | entrapment |
48 | ″ | ″ | failure |
49 | ″ | ″ | failure model |
50 | ″ | ″ | failure patients |
51 | ″ | ″ | first phase |
52 | ″ | ″ | flow rate control |
53 | ″ | ″ | formation |
54 | ″ | ″ | function |
55 | ″ | ″ | further investigation |
56 | ″ | ″ | gel contraction |
57 | ″ | ″ | hepatocyte spheroids |
58 | ″ | ″ | hepatocytes |
59 | ″ | ″ | high levels |
60 | ″ | ″ | high yield |
61 | ″ | ″ | higher liver-specific functions |
62 | ″ | ″ | hollow fiber bioreactor |
63 | ″ | ″ | improved survival |
64 | ″ | ″ | investigation |
65 | ″ | ″ | large-scale preparation |
66 | ″ | ″ | levels |
67 | ″ | ″ | liver |
68 | ″ | ″ | liver failure |
69 | ″ | ″ | liver failure model |
70 | ″ | ″ | liver failure patients |
71 | ″ | ″ | liver-specific activity |
72 | ″ | ″ | liver-specific functions |
73 | ″ | ″ | liver-specific metabolic activity |
74 | ″ | ″ | luminal side |
75 | ″ | ″ | major cause |
76 | ″ | ″ | measurements |
77 | ″ | ″ | metabolic activity |
78 | ″ | ″ | mixture |
79 | ″ | ″ | mixture of spheroids |
80 | ″ | ″ | model |
81 | ″ | ″ | monolayer cultures |
82 | ″ | ″ | monolayers |
83 | ″ | ″ | mortality |
84 | ″ | ″ | number |
85 | ″ | ″ | order |
86 | ″ | ″ | overdose |
87 | ″ | ″ | oxygen measurements |
88 | ″ | ″ | oxygenator |
89 | ″ | ″ | patients |
90 | ″ | ″ | perfusion protocol |
91 | ″ | ″ | phase |
92 | ″ | ″ | porcine hepatocytes |
93 | ″ | ″ | possibility |
94 | ″ | ″ | preparation |
95 | ″ | ″ | proper degree |
96 | ″ | ″ | protocol |
97 | ″ | ″ | rabbits |
98 | ″ | ″ | rat hepatocytes |
99 | ″ | ″ | rate control |
100 | ″ | ″ | rats |
101 | ″ | ″ | requirements |
102 | ″ | ″ | scale |
103 | ″ | ″ | self-assembled spheroids |
104 | ″ | ″ | series |
105 | ″ | ″ | side |
106 | ″ | ″ | spheroid formation |
107 | ″ | ″ | spheroids |
108 | ″ | ″ | study |
109 | ″ | ″ | sufficient number |
110 | ″ | ″ | support |
111 | ″ | ″ | surface requirements |
112 | ″ | ″ | survival |
113 | ″ | ″ | suspension |
114 | ″ | ″ | system |
115 | ″ | ″ | tank |
116 | ″ | ″ | tank bioreactor |
117 | ″ | ″ | temporary support |
118 | ″ | ″ | test animals |
119 | ″ | ″ | treatment |
120 | ″ | ″ | use |
121 | ″ | ″ | viability |
122 | ″ | ″ | warrants further investigation |
123 | ″ | ″ | xenogeneic hepatocytes |
124 | ″ | ″ | yield |
125 | ″ | schema:name | Development of a bioartificial liver employing xenogeneic hepatocytes |
126 | ″ | schema:pagination | 29-38 |
127 | ″ | schema:productId | N17ae26d82b074bf4b655ad8b845a11b1 |
128 | ″ | ″ | N36266ecd9a774a7b9bc7b8958dadc123 |
129 | ″ | ″ | N9b49bc3f653643e9ace1f767b62b8b4e |
130 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1002483814 |
131 | ″ | ″ | https://doi.org/10.1023/a:1007906512616 |
132 | ″ | schema:sdDatePublished | 2022-05-20T07:20 |
133 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
134 | ″ | schema:sdPublisher | Nd739e2804045463491ee6b13b0cf9605 |
135 | ″ | schema:url | https://doi.org/10.1023/a:1007906512616 |
136 | ″ | sgo:license | sg:explorer/license/ |
137 | ″ | sgo:sdDataset | articles |
138 | ″ | rdf:type | schema:ScholarlyArticle |
139 | N17ae26d82b074bf4b655ad8b845a11b1 | schema:name | dimensions_id |
140 | ″ | schema:value | pub.1002483814 |
141 | ″ | rdf:type | schema:PropertyValue |
142 | N20f6ba27c13147f885a5ee7acfa390b0 | rdf:first | sg:person.0642163715.45 |
143 | ″ | rdf:rest | N2564a0853851499cbd8bb20899aef5f9 |
144 | N2564a0853851499cbd8bb20899aef5f9 | rdf:first | sg:person.01365570015.47 |
145 | ″ | rdf:rest | N8bf53bc43d1344b8b26d844d0f35ed98 |
146 | N2edeefe42b87456b837a900d86f627be | schema:issueNumber | 1-3 |
147 | ″ | rdf:type | schema:PublicationIssue |
148 | N36266ecd9a774a7b9bc7b8958dadc123 | schema:name | doi |
149 | ″ | schema:value | 10.1023/a:1007906512616 |
150 | ″ | rdf:type | schema:PropertyValue |
151 | N3e2236148741481f9a0fd2d919d74908 | rdf:first | sg:person.01267470403.44 |
152 | ″ | rdf:rest | N82c064b600234e2e89f2ed6ebccef017 |
153 | N41daae4077c447fa86dc7281f06321e9 | rdf:first | sg:person.01306202160.55 |
154 | ″ | rdf:rest | N77b47d36df544f30850189a4857549e3 |
155 | N4fa158472719424b88b8d6d9f540b446 | rdf:first | sg:person.01260246357.46 |
156 | ″ | rdf:rest | N3e2236148741481f9a0fd2d919d74908 |
157 | N610be4845a6a4a93b0052afc66f1f635 | rdf:first | sg:person.01064261433.49 |
158 | ″ | rdf:rest | N20f6ba27c13147f885a5ee7acfa390b0 |
159 | N77b47d36df544f30850189a4857549e3 | rdf:first | sg:person.016461535432.57 |
160 | ″ | rdf:rest | N4fa158472719424b88b8d6d9f540b446 |
161 | N82c064b600234e2e89f2ed6ebccef017 | rdf:first | sg:person.015711213420.76 |
162 | ″ | rdf:rest | rdf:nil |
163 | N8bf53bc43d1344b8b26d844d0f35ed98 | rdf:first | sg:person.0667256104.98 |
164 | ″ | rdf:rest | N41daae4077c447fa86dc7281f06321e9 |
165 | N9b49bc3f653643e9ace1f767b62b8b4e | schema:name | pubmed_id |
166 | ″ | schema:value | 22358518 |
167 | ″ | rdf:type | schema:PropertyValue |
168 | Nd739e2804045463491ee6b13b0cf9605 | schema:name | Springer Nature - SN SciGraph project |
169 | ″ | rdf:type | schema:Organization |
170 | Nd923715ab7334466b14237f9b254bbbb | schema:volumeNumber | 23 |
171 | ″ | rdf:type | schema:PublicationVolume |
172 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
173 | ″ | schema:name | Biological Sciences |
174 | ″ | rdf:type | schema:DefinedTerm |
175 | anzsrc-for:10 | schema:inDefinedTermSet | anzsrc-for: |
176 | ″ | schema:name | Technology |
177 | ″ | rdf:type | schema:DefinedTerm |
178 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
179 | ″ | schema:name | Medical and Health Sciences |
180 | ″ | rdf:type | schema:DefinedTerm |
181 | sg:journal.1086307 | schema:issn | 1381-5741 |
182 | ″ | ″ | 1573-0603 |
183 | ″ | schema:name | Cytotechnology |
184 | ″ | schema:publisher | Springer Nature |
185 | ″ | rdf:type | schema:Periodical |
186 | sg:person.01064261433.49 | schema:affiliation | grid-institutes:grid.17635.36 |
187 | ″ | schema:familyName | Hu |
188 | ″ | schema:givenName | Wei-Shou |
189 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064261433.49 |
190 | ″ | rdf:type | schema:Person |
191 | sg:person.01260246357.46 | schema:affiliation | grid-institutes:grid.17635.36 |
192 | ″ | schema:familyName | Nyberg |
193 | ″ | schema:givenName | Scott L. |
194 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260246357.46 |
195 | ″ | rdf:type | schema:Person |
196 | sg:person.01267470403.44 | schema:affiliation | grid-institutes:grid.17635.36 |
197 | ″ | schema:familyName | Remmel |
198 | ″ | schema:givenName | Rory P. |
199 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267470403.44 |
200 | ″ | rdf:type | schema:Person |
201 | sg:person.01306202160.55 | schema:affiliation | grid-institutes:grid.17635.36 |
202 | ″ | schema:familyName | Peshwa |
203 | ″ | schema:givenName | Madhusudan V. |
204 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306202160.55 |
205 | ″ | rdf:type | schema:Person |
206 | sg:person.01365570015.47 | schema:affiliation | grid-institutes:grid.17635.36 |
207 | ″ | schema:familyName | Wu |
208 | ″ | schema:givenName | Florence J. |
209 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365570015.47 |
210 | ″ | rdf:type | schema:Person |
211 | sg:person.015711213420.76 | schema:affiliation | grid-institutes:grid.17635.36 |
212 | ″ | schema:familyName | Cerra |
213 | ″ | schema:givenName | Frank B. |
214 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015711213420.76 |
215 | ″ | rdf:type | schema:Person |
216 | sg:person.016461535432.57 | schema:affiliation | grid-institutes:grid.17635.36 |
217 | ″ | schema:familyName | Lazar |
218 | ″ | schema:givenName | Arye |
219 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016461535432.57 |
220 | ″ | rdf:type | schema:Person |
221 | sg:person.0642163715.45 | schema:affiliation | grid-institutes:grid.17635.36 |
222 | ″ | schema:familyName | Friend |
223 | ″ | schema:givenName | Julie R. |
224 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642163715.45 |
225 | ″ | rdf:type | schema:Person |
226 | sg:person.0667256104.98 | schema:affiliation | grid-institutes:grid.17635.36 |
227 | ″ | schema:familyName | Sielaff |
228 | ″ | schema:givenName | Timothy |
229 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667256104.98 |
230 | ″ | rdf:type | schema:Person |
231 | sg:pub.10.1007/978-3-642-96629-3_41 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1000888130 |
232 | ″ | ″ | https://doi.org/10.1007/978-3-642-96629-3_41 |
233 | ″ | rdf:type | schema:CreativeWork |
234 | sg:pub.10.1007/978-3-642-96629-3_43 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1007304278 |
235 | ″ | ″ | https://doi.org/10.1007/978-3-642-96629-3_43 |
236 | ″ | rdf:type | schema:CreativeWork |
237 | sg:pub.10.1007/bf01307531 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1020837436 |
238 | ″ | ″ | https://doi.org/10.1007/bf01307531 |
239 | ″ | rdf:type | schema:CreativeWork |
240 | sg:pub.10.1007/bf02626175 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1032988930 |
241 | ″ | ″ | https://doi.org/10.1007/bf02626175 |
242 | ″ | rdf:type | schema:CreativeWork |
243 | sg:pub.10.1007/bf02634282 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1020247813 |
244 | ″ | ″ | https://doi.org/10.1007/bf02634282 |
245 | ″ | rdf:type | schema:CreativeWork |
246 | sg:pub.10.1007/bf02722946 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1028865471 |
247 | ″ | ″ | https://doi.org/10.1007/bf02722946 |
248 | ″ | rdf:type | schema:CreativeWork |
249 | sg:pub.10.1007/bf02782889 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1082827506 |
250 | ″ | ″ | https://doi.org/10.1007/bf02782889 |
251 | ″ | rdf:type | schema:CreativeWork |
252 | grid-institutes:grid.17635.36 | schema:alternateName | Department of Medicinal Chemistry, University of Minnesota, 55455–0132, Minneapolis, MN |
253 | ″ | ″ | Department of Surgery, University of Minnesota, 55455–0132, Minneapolis, MN |
254 | ″ | ″ | Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455–0132, Minneapolis, MN |
255 | ″ | schema:name | Department of Medicinal Chemistry, University of Minnesota, 55455–0132, Minneapolis, MN |
256 | ″ | ″ | Department of Surgery, University of Minnesota, 55455–0132, Minneapolis, MN |
257 | ″ | ″ | Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455–0132, Minneapolis, MN |
258 | ″ | rdf:type | schema:Organization |